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Introduction
Retinopathy of prematurity (ROP) and diabetic retinopathy (DR) are potentially blinding disorders that affect premature infants and working age adults, respectively in US (Aiello et al., 1998; Chen and Smith, 2007) . ROP and DR follow a pathological progression pattern characteristic of ischemic retinopathy, where the loss of retinal capillary is an early initiating event, leading to a poorly controlled process of retinal neovascularization and the development of proliferative retinopathy (for review see ). So far, the golden standard treatment for retinal neovascularization is limited to laser photocoagulation. Although successful, this treatment is invasive and results in loss of peripheral vision (for review see (Ali and ElRemessy, 2009) ). The lack of approved pharmacological treatment for DR and ROP creates a great need for finding new effective therapeutic modalities to treat these devastating diseases.
Accordingly, the mechanisms that control the process of retinal neovascularization are therefore of major clinical importance.
Peroxynitrite formed by reaction of nitric oxide and superoxide anion, mediates a variety of biological processes including inhibition of key metabolic enzymes, lipid peroxidation, nitration of the protein tyrosine residue and reduction of cellular antioxidant defenses by oxidation of thiol pools (Pacher et al., 2007) . A critical role of increased oxidative stress and in particular the peroxynitrite is supported by previous studies showing that increases in peroxynitrite formation causes capillary endothelial cells apoptosis leading to vascular cell loss in DR and ROP models (Brooks et al., 2001; Gu et al., 2002; Sennlaub et al., 2002; Beauchamp et al., 2004; Kowluru and Odenbach, 2004; Kowluru et al., 2007) . Moreover, clinical studies showed that infants with active ROP have low serum levels of reduced glutathione (GSH) suggesting compromised antiThis article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 8, 2009 as DOI: 10.1124 at ASPET Journals on July 7, 2017 jpet.aspetjournals.org Downloaded from JPET#157941 5 oxidant defense (Papp et al., 1999; Wright et al., 2006) . We and others have shown that increased peroxynitrite formation correlates with capillary endothelial cells apoptosis (Du et al., 2002; Sennlaub et al., 2002; Zou et al., 2002; Gu et al., 2003; El-Remessy et al., 2005; Drel et al., 2008) . However, the molecular mechanism for peroxynitrite-induced vascular cell death and the therapeutic role of blocking tyrosine nitration were not investigated in models of ischemic retinopathy.
In the present study, we took the advantage of using ischemic retinopathy mouse model as it has two distinguished stages: initial stage of hyperoxia 75% oxygen characterized with excessive peroxynitrite formation and capillary drop out followed by a later stage of hypoxia 21% oxygen characterized with mild oxidative insult and retinal neovascularization El-Remessy et al., 2007) . We compared the effects of selectively blocking the tyrosine nitration using epicatechin, one of the green tea extracts that has no antioxidant properties but selectively inhibits tyrosine nitration process, versus FeTPPs the specific peroxynitrite decomposition catalyst or N-Acetyl cysteine (NAC) which is a dietary supplement, general antioxidant and a thiol donor. While we showed previously that blocking tyrosine nitration using the selective nitration inhibitor epicatechin can restore VEGF survival signal , it enhances VEGF's angiogenic signal in vitro and retinal neovascularization in vivo (ElRemessy et al., 2007) .
Our previous studies showed that high levels of peroxynitrite inhibit prosurvival signal of VEGF and bFGF and cause endothelial cell death in culture models of diabetic retinopathy and retinopathy of prematurity (Gu et al., 2003; El-Remessy et al., 2005) . Here, we elucidate the molecular mechanism by which peroxynitrite-mediated tyrosine nitration can inhibit p85 subunit This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 8, 2009 as DOI: 10.1124 at ASPET Journals on July 7, 2017 jpet.aspetjournals.org Downloaded from JPET#157941 6 of PI 3-kinase and trigger vascular cell death in vivo. We also investigate the effects of the early intervention of tyrosine nitration on preventing retinal vascular cell death and vaso-obliteration during hyperoxic stage (p7-p12) and the continuous intervention (p7-p17) on preventing retinal neovascularization. Our results suggest that early blocking tyrosine nitration and peroxynitrite formation could be considered as a new effective therapeutic target for a possible control of common ischemic proliferative retinopathy diseases.
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Materials and Methods
Cell culture
Primary cultures of bovine retinal endothelial (BRE) cells were prepared as described previously (El-Remessy et al., 2007) . Cells from passages 4-8 were used in all experiments. Cells were maintained in M199 supplemented with 10% FBS, 10% CS-C complete medium, 2 mM glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C in a humidified CO 2 incubator.
Treatment during hyperoxia and normoxia: BREC were grown to 80% confluence and then switched to serum-free medium and placed in a hyperoxic (40% O 2 , 5% CO 2 ) or normoxic (21% O 2 , 5% CO 2 ) environment for 48 h unless otherwise indicated. The 40% O 2 level was chosen for hyperoxia 40% oxygen exposure on the basis of previous research showing that 40% O 2 generates significant peroxynitrite without inducing toxicity in retinal cells (Gu et al., 2003) . The hyperoxia 40% oxygen exposure was performed in a humidified incubator modified by installing the PROOX model 110 oxygen regulator (Biospherix, Redfield, NY).The oxygen level was continuously monitored using the PROOX oxygen sensor.
Animals
All experiments were performed using C57Bl/6 mice and were approved by the institutional 
Ischemic retinopathy mouse model
Following the protocol of (Smith et al., 1994) , on postnatal day 7 (p7) newborn mice were placed along with their dams into a custom-built chamber in which the partial pressure of oxygen This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 8, 2009 as DOI: 10.1124 at ASPET Journals on July 7, 2017 jpet.aspetjournals.org Downloaded from JPET#157941 8 was maintained at 75% (Biospherix , Redfield, NY). Mice were maintained in 75% oxygen for up to 5 days (p12), after which they were transferred back to room air (relative hypoxia 21% oxygen). Room temperature was maintained at 20 0 C, and rooms were illuminated with standard fluorescent lighting on a 12-hour light-dark cycle. Newborn mice were nursed by the dams that were given food (standard mouse chow) and water.
Treatment during hyperoxia and hypoxia periods: Animals were treated by daily intraperitoneal injections (IP) with the following inhibitors: peroxynitrite decomposition catalyst 5, 10, 15, 20 tetrakis (4sulfonatophenyl) porphyrinato iron III chloride (FeTPPs, 1mg/Kg, Calbiochem), the nitration inhibitor, (−)-cis-3,3′,4′,5,7-Pentahydroxyflavane, (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, (epicatechin, 10mg/Kg, Sigma), or the general antioxidant, N-acetyl cysteine (NAC, 150mg/Kg Sigma). Animals were treated either during hyperoxia stage (75% oxygen) only (p7-p12) or during hyperoxia (75% oxygen) and hypoxia stage 21% oxygen (p7-p17). Control animals were injected with the vehicle. The treatment regimen was optimized and described before (El-Remessy et al., 2007) .
Dissecting retinal tissue:
Pups were deeply anesthetized by IP injection of Avertin 240 mg/Kg.
One eye was enucleated and fixed in 2% PFA overnight to be flat-mounted. For the other eye, retinas were isolated and snap frozen for biochemical assays.
Analysis of Vaso-Obliteration and Neovascularization
Retinal vascular distribution was analyzed using retinal flat mounts labeled with biotinylated , 2005) . The areas of retinal neovascularization were assessed on p17 as described previously (El-Remessy et al., 2007) .
Oxidized and reduced Glutathione ratio
Total glutathione including reduced (GSH) and oxidized (GSSG) were measured using a kit (Northwest Life Science, Vancouver, WA) according to manufacturer's protocol. For total glutathione, retinas were lysed in phosphate buffer (100mM potassium phosphate and 1mM EDTA) and were mixed with an equal amount of DTNB (10 mM 5, 5'-dithiobis (2-nitrobenzoic acid) in the presence of glutathione reductase and NADPH producing a measurable yellow color.
The color was measured at a wavelength of 412 nm. To detect GSSG, samples were treated with 10 mM 2-vinylpyridine (Sigma, St. Louis, MO) in ethanol to sequester all the reduced GSH then measured using the same protocol of the glutathione. GSH was calculated as the difference between total glutathione and GSSG.
Determination of retinal lipid peroxides
The assay was performed on retinal lysates as described before . Briefly, retinal lysate is reacted with 20% Acetic Acid, 8% SDS and thiobarbituric acid at 95°C for 60 min and the reaction was cooled down on ice. The samples were centrifuged and the supernatant was extracted with n-butanol and pyridine (15:1 respectively) and the absorbance of the organic solvent layer measured at 532 nm. The results were compared with an external standard 
Western blotting analysis
Retinas and BREC were harvested after various treatments and lysed in modified RIPA buffer (Millipore, Billerica, MA) 30 min on ice. Insoluble material was removed by centrifugation at 14,000 g at 4°C for 30 min. 50 µg of total protein were boiled in 6x Laemmli sample buffer, separated on a 10-12% SDS-polyacrylamide gel by electrophoresis, transferred to nitrocellulose, and reacted with specific antibody. The primary antibodies for cleaved caspase-3, phosphor-p38, p38, phospho-Akt, or Akt were obtained from (Cell Signaling, Boston, MA) and were detected using a horseradish peroxidase-conjugated antibody and enhanced chemiluminescence (Amersham BioSciences).The films were subsequently scanned, and band intensity was quantified using densitometry software (Alpa Innotech). For PI 3-kinase tyrosine nitration, retinal lysates were incubated with p85 antibody and A/G agarose beads overnight. The precipitated proteins were analyzed by SDS-PAGE and blotted with nitrotyrosine antibody or p85 for equal loading as described above. Antibodies for p85 subunit of the PI-3 kinase and nitrotyrosine were obtained from (Millipore, Billerica, MA). For VEGF, retinal lysates were subjected to heparin beads (Sigma, St. Louis, MO) as described before . Briefly, the beads were pelleted at 5000 x g for 1 min, washed in 400 mM NaCl and 20 mM Tris and loaded onto a 4-20% gradient Tris glycine pre-cast gel (BioRad, Hercules, CA). After blocking, the membrane was incubated with VEGF primary antibody (Calbiocam, Gibbstown, NJ). The band was visualized and quantified as described above.
Detection of nitrotyrosine
This article has not been copyedited and formatted. The final version may differ from this version. Relative amounts of proteins nitrated on tyrosine were measured using slot-blot techniques as described previously . Briefly, RIPA lysate were immobilized onto nitrocellulose membrane by using a slot blot microfiltration unit (Bio-Rad, Hercules, CA). A dilution series of peroxynitrite-modified BSA (Cayman Chemical, Ann Harper, MI) was loaded to generate a standard curve, and nitrotyrosine was detected using a polyclonal anti-nitrotyrosine antibody (Millipore, Temecula, CA) followed by peroxidase-labeled goat anti-mouse IgG and ECL. Relative levels of nitrotyrosine immunoreactivity were determined by densitometry software (Alpa Innotech).
Data Analysis
The results were expressed as mean ± SE. Difference among experimental groups were evaluated by analysis of variance, and the significance of difference between groups was assessed by the post-hoc test (Fisher's PLSD) when indicated. Significance was defined as P < 0.05. 
Results
Blocking tyrosine nitration decreases retinal vaso-obliteration
Previous studies showed a positive correlation between retinal vascular cell death, increases in peroxynitrite formation and tyrosine nitration. Therefore, we screened the protective effects of selective inhibition of tyrosine nitration using epicatechin or the general antioxidant and the thiol donor N-acetyl cysteine (NAC) versus decomposing peroxynitrite using (FeTPPs), a selective peroxynitrite decomposition catalyst. As shown in ( These results suggest that selective blocking of tyrosine nitration has protective effect comparable to decomposing peroxynitrite or preventing thiol oxidation on retinal vascular cell death.
Blocking tyrosine nitration prevents retinal apoptosis
Apoptosis has been postulated as the mechanism by which vascular cell death occurs in ischemic retinopathy. Therefore, we investigated the expression of apoptotic markers prior to p12.
Exposing the retina (p7-p9) to high oxygen resulted in increases in cleaved caspase-3 (Fig. 2.A) .
Treatment with FeTPPs, epicatechin, or NAC significantly reduced cleaved caspase-3 with 46.5%, 51%, 43.5% respectively (Fig. 2.A) . Apoptosis was further confirmed by detecting poly-ADP-ribose polymerase (PARP), a cleavage target of caspase-3 (Fig. 2. 
B). Retinas exposed to
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Effect of inhibition of tyrosine nitration on VEGF
Down-regulation of VEGF expression has been postulated to cause vaso-obliteration of the newly formed capillaries (Alon et al., 1995) . Therefore, we tested whether the protective effects of blocking tyrosine nitration on preventing retinal vaso-obliteration involve alteration of VEGF expression. As shown in Fig. 3 , exposing the retina (p7-p12) to high oxygen resulted in modest but significant decreases in VEGF expression compared to retinas developed at normal oxygen.
Interestingly, treatment with FeTPPs, epicatechin, or NAC did not affect VEGF expression compared to PBS-treated pups (Fig. 3) .
Blocking tyrosine nitration selectively decreases nitrative stress
The retina is believed to be vulnerable to nitrative and oxidative damage because of the abundance of polyunsaturated fatty acids. Hyperoxia (75% oxygen) showed a significant increase in the nitrotyrosine formation compared to normoxia (21% oxygen) (Fig. 4.A) .
Treatment of pups with FeTPPs, epicatechin, or NAC significantly decreased nitrotyrosine formation (50%, 58% and 60% respectively). In addition to tyrosine nitration, peroxynitrite can cause thiol oxidation which compromises antioxidant defense. Measuring the ratio between the cellular oxidized to reduced glutathione is used as a marker for the retinal antioxidant defense.
Normal tissue has a balanced ratio between oxidized and reduced glutathione. As shown in (Fig.   4 .B) Retinas from p12 pups exposed to high oxygen showed (4-fold) increases in tissue GSSG/GSH ratio. Treatment with either FeTPPs or NAC significantly restored the GSSG/GSH This article has not been copyedited and formatted. The final version may differ from this version. 
Hyperoxia causes tyrosine nitration of p85 subunit of PI 3-kinase
Our previous work has shown that the p85 regulatory subunit of PI 3-kinase is a susceptible target for peroxynitrite-induced tyrosine nitration in endothelial cells .
As shown in (Fig 5.A) , retinas from p12 that were exposed to high oxygen showed a (4-fold) increase in tyrosine nitration of p85 compared to normoxia (21% oxygen). Treatment (p7-p12) with epicatechin or NAC significantly reduced the nitrating effect of peroxynitrite on tyrosine residues similar to decomposing peroxynitrite with FeTPPs.
Hyperoxia-induced nitration inhibits Akt survival and activates p38 MAP kinase
As the retina is composed of several cell types, we further examined the role of tyrosine nitration in hyperoxia-induced vascular cell death. Bovine retinal endothelial (BRE) cells were cultured in high oxygen conditions (40%) and compared to normoxia (21%). BRE cells showed 2.3-fold increase in tyrosine nitration of the p85 subunit compared to normoxia (21% oxygen) (Fig. 5.B) .
Treatment with FeTPPs (2.5 μM), epicatechin (100 μM) or NAC (1 mM) for 48 hrs significantly reduced hyperoxia-induced p85 tyrosine nitration (Fig. 5.B) . To confirm the inhibitory effect of tyrosine nitration on PI3-Kinase, we tested the effects of inhibitors on Akt phosphorylation. Akt, a down stream target of PI3-Kinase, mediates cell survival by inhibiting apoptotic processes.
Hyperoxia (40% oxygen) significantly decreased Akt phosphorylation compared to normoxia (21% oxygen) by 40 % (Fig 6.A) . Treating cells with FeTPPs, epicatechin or NAC for 48 hrs restored Akt activation. PI 3-kinase/Akt signaling promotes endothelial cell survival by inhibiting p38 MAPK-dependent apoptosis (Gratton et al., 2001) . Therefore, blockade of PI 3- showed 2-fold in p38 MAPK phosphorylation that was decreased by treatment with FeTPPs, epicatechin or NAC. Increases in p38 MAPK phosphorylation were also observed in p12 retinas subjected to high oxygen compared to controls (Fig 6.C) . Retinas from PBS-treated pups showed 2-fold increase in p38 MAPK phosphorylation compared to normoxia (21% oxygen). Treatments with FeTPPs, epicatechin or NAC reduced p38 MAPK phosphorylation by 34.6%, 36.6% and 49.1% respectively. Next, we evaluated the effects of hyperoxia (40% oxygen) to induce endothelial cell apoptosis. As shown in Fig. 6 .D, hyperoxia (40% oxygen) induced endothelial cell apoptosis as indicated by increased expression of cleaved caspase-3. Blocking tyrosine nitration with FeTPPs, epicatechin or NAC protected the cells against apoptosis by decreasing the level of cleaved caspase-3 by 50%, 43% and 46% respectively.
Early intervention of tyrosine nitration prevents retinal oxidative injury.
Lipid peroxidation has been established as a general marker of oxidative stress and cellular injury. As shown in Fig. 7A , retinas from pups that underwent hyperoxia (75% oxygen) and hypoxia 21% oxygen (p7-p17) showed high levels of lipid peroxides compared to the one in normal air. Early intervention with FeTPPs, epicatechin or the thiol donor NAC decreased lipid peroxidation hence the cellular injury. Interestingly, treatment with FeTPPs or the thiol donor NAC, but not epicatechin restored the antioxidant defense as indicated by the ratio of GSSG to GSH (Fig. 7.B) . These results confirm the effect of epicatechin in selectively blocking tyrosine nitration without exerting antioxidant effect. This 
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Early intervention of tyrosine nitration prevents retinal neovascularization
Our previous studies showed that blocking nitration after vaso-obliteration (p12-p17) did not prevent retinal neovascularization (El-Remessy et al., 2007) . Here we tested the long-term protective effects of blocking tyrosine nitration during both hyperoxia (75% oxygen) and hypoxia 21% oxygen (p7-p17). Compared to PBS-treated pups, treatment with epicatechin significantly (62.1%) reduced retinal neovascularization. This effect was comparable but to lesser extent to pups treated with FeTPPs or NAC by 76.8% and 71.5% respective reduction in neovascularization ( Fig. 8 .A-E).
Next, we measured the capillary drop out areas at the end of hypoxia 21% oxygen (p17) to test the effect of treatment on the physiological revascularization in the central retina. As expected in this model, PBS-treated controls showed a 29% reduction in capillary drop out areas compared to the one at the end of hyperoxia (75% oxygen) (p12). Treatment with FeTPPs, epicatechin or NAC further reduced capillary drop out areas by 55%, 50%, and 60% respectively compared to p17 PBS-treated animals; suggesting that blocking peroxynitrite did not alter physiological revascularization; instead, it enhanced vascular regrowth and continued protecting from vasoobliteration (Fig 8.F) .
Discussion
The present study documents novel data suggesting that 1) Peroxynitrite mediates retinal vasoobliteration via tyrosine nitration of p85 kinase and inhibition of PI 3kinase/Akt survival pathway; 2) Blocking tyrosine nitration restores survival signal and prevents endothelial cell apoptosis and retinal ischemia and 3) early intervention with treatments that target peroxynitrite and tyrosine nitration prevents retinal neovascularization. To our knowledge this is the first in vivo study to elucidate the mechanism by which peroxynitrite-mediated tyrosine nitration and inhibition of PI 3-kinase survival pathway trigger vascular cell death in ischemic retinopathy model. Our results also demonstrate that targeting tyrosine nitration with dietary supplements such as epicatechin and NAC represent potentially safe and effective therapeutic strategy that could be translated to patients with ischemic-proliferative diseases.
The focus of the current study is to test the protective effects of blocking peroxynitrite and tyrosine nitration on retinal cell death in vitro and on preventing vaso-obliteration and neovascularization in vivo. Therefore, we took the advantage of using ischemic retinopathy mouse model as it has two distinguished stages: initial vascular cell death and vaso-obliteration, which are associated with excessive peroxynitrite formation followed by retinal neovascularization which is associated with mild oxidative insult (Papp et al., 1999; Brooks et al., 2001; Gu et al., 2002; Beauchamp et al., 2004; Wright et al., 2006; Bartoli et al., 2008) . Our results showing that hyperoxia caused significant increases in cleaved PARP, the caspase-3 substrate in vitro and in vivo lend further support to the previous reports of the critical role of caspase-3 in executing peroxynitrite-induced apoptosis in endothelial cells (Kotamraju et al., 2001; Gu et al., 2003; Zhu et al., 2004; El-Remessy et al., 2005) . Treatment with epicatechin blocked tyrosine nitration and significantly reduced capillary dropout areas and the expression of cleaved caspase-3 and PARP.
However, epicatechin did not alter GSSG/GSH ratio confirming its selective properties in blocking tyrosine nitration but not thiol oxidation. On the other hand, treatment with FeTPPs or NAC not only blocked tyrosine nitration but also improved GSSG/GSH ratio indicating restoration of retinal antioxidant defense which explain the superior effects of NAC and FeTPPs in reducing vaso-obliteration over epicatechin. In contrast, NAC failed to show protective effects on reducing retinal avascularity and apoptosis in a rat model of ROP that could be attributed to the different nature of model and shorter duration of treatment (Saito et al., 2007) .
Our results establish a unique role of selective blocking tyrosine nitration, apart from the antioxidant effect, in preventing retinal vaso-obliteration and support the notion of its therapeutic intervention for ischemic retinal diseases. To elucidate the molecular mechanisms by which blocking tyrosine nitration protect the retina from apoptosis, we determined the expression of VEGF as its down-regulation has been postulated to cause vaso-obliteration of the newly formed capillaries (Alon et al., 1995) . In agreement, our results showed modest but significant decrease in VEGF expression in hyperoxic retinas. However, treatment with FeTPPs, epicatechin or NAC did not alter VEGF expression compared to PBS-treated ones. These results suggest that the protective effects of blocking peroxynitrite and tyrosine nitration in preventing retinal apoptosis and vaso-obliteration are not mediated by altering VEGF expression level, instead by modulating VEGF signal.
VEGF's function as a survival factor for endothelial cells is well established (Duh and Aiello, 1999) . VEGF activation of VEGFR2 transduces anti-apoptic signal via PI 3-kinase/Akt signaling pathway (Gerber et al., 1998; Fujio and Walsh, 1999) . Tyrosine nitration and subsequent inhibition of the p85 regulatory subunit of PI 3-kinase have been documented in response to peroxynitrite (Hellberg et al., 1998; El-Remessy et al., 2005) . Here, we show that retinas from pups exposed to hyperoxia (75% oxygen) showed significant increases (4-fold) in tyrosine nitration of p85 subunit compared to pups in normoxia (21% oxygen). Similar pattern was observed in retinal endothelial cultures maintained at hyperoxia (75% oxygen) compared to the one maintained at normal oxygen. These effects were associated with impaired Akt phosphorylation, increased p38 MAPK phosphorylation and increased expression of the apoptotic marker caspase-3. Treatment with epicatechin or NAC had comparable effects to peroxynitrite. Our findings lend further support to previous reports of significant increases in oxidative and nitrative stress in ischemic retinopathy model (Papp et al., 1999; Brooks et al., 2001; Gu et al., 2002; Gu et al., 2003; Beauchamp et al., 2004; Saito et al., 2007; Medina et al., 2008) . Understanding of the molecular pathogenesis of ischemic retinopathy provides the basis for identifying novel therapeutic targets. The role of the hypoxia induced factors VEGF and erythropoietin as well as the maternally-derived factors insulin-like growth factor-1 have begun to be elucidated (see review (Heidary et al., 2009) ). However, our study is the first we know of that elucidates the molecular mechanism of the tyrosine nitration of p85 leading to inactivation of, the PI 3-kinase/Akt survival signal and activation of the pro-apoptotic p38 MAPK signal in ischemic retinopathy model. A scheme of the proposed mechanism is depicted in Fig. 9 . These findings explain the protective effects of epicatechin in preventing vaso-obliteration even though it did not completely restore retinal anti-oxidant defense.
Retinal neovascularization takes place as result of initial stage of capillary loss leading to inner retinal ischemia that drives up-regulation of angiogenic growth factors (Mizutani et al., 1996) .
The combined vascular protection of reducing pathological neovascularization while allowing physiological revascularization of the retina is the ideal therapeutic modality for ischemic retinopathy diseases. Therefore, it is critical to evaluate the effects of early blocking of tyrosine nitration and capillary drop out on preventing the subsequent neovascularization. Continuous intervention of tyrosine nitration during both hyperoxia (75% oxygen) and hypoxia 21% oxygen preventing earlier vaso-obliteration and hence the stimulus to neovascularization. This concept is further supported by our previous findings that late intervention with epicatechin after vasoobliteration (p12-p17) did not prevent retinal neovascularization ElRemessy et al., 2007) . The vascular protective effects of NAC and FeTPPs were associated with restoration of anti-oxidant defense as indicated by GSSG/GSH ratio, but not of epicatechin confirming its selective effect of inhibiting tyrosine nitration apart from thiol oxidation. While the vascular protective effects of FeTPPs are significant, the fact that it contains iron will limit its therapeutic use for chronic administration. The vascular effects of NAC were superior to epicatechin but did not reach significance and this could be attributed to the antioxidant of NAC over epicatechin. New studies showed that NAC also may have other mechanism that can interfere with cell proliferation by regulating the cell cycle regulatory protein (Menon et al., 2007) . However, both epicatechin and NAC prove effective and the fact that they are already available as dietary supplement open the door for therapeutic utility. Together, these results point out the importance of the timing and the molecular target of intervention. In support, studies using the same ischemic retinopathy model showed that early intervention with omega-3 polyunsaturated fatty acid failed to rescue oxygen-induced vessel loss during hyperoxia (75% oxygen) but prevented late retinal neovascularization (Connor et al., 2007) . On the other hand, intervention with statins effectively reduced retinal oxidative stress, capillary drop out and prevented neovascularization (Bartoli et al., 2008; Medina et al., 2008) .
In conclusion, our study is the first to elucidate the mechanism by which tyrosine nitration of p85 (n=4, *P<0.05, VS normoxia 21% oxygen). 
